Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: patient recorded as having no known allergies to drugs attending: chief complaint: chf/a fib/doe major surgical or invasive procedure: mv repair (34 mm annuloplasty ring) history of present illness: 79 yo male recently treated for chf ( lost 28 # with med rx). prior to med management, he was experiencing doe and had decreased activity tolerance. has been followed with echos for 5 years. most recent shows moderate to severe mr. past medical history: mr cad htn systolic chf rhd a fib pud with gastric bleed varicosities cri social history: lives with wife denies tobacco use denies etoh use retired engineer family history: nc physical exam: 5'8" 114# right 104/70 left 108/72 hr 88 rr 14 nad skin unremarkable perrl/eomi/ncat neck supple, full rom, no jvd or carotid bruits appreciated ctab regularly irregular holosystolic murmur soft, nt, nd extrems warm, well-perfused, 1+ le edema large bilat. varicosities, right greater than left pertinent results: conclusions prebypass 1. the left atrium is mildly dilated. no spontaneous echo contrast or thrombus is seen in the body of the left atrium or left atrial appendage. no atrial septal defect is seen by 2d or color doppler. 2. the left ventricular cavity is moderately dilated. overall left ventricular systolic function is severely depressed (lvef= 20-25 %), in the setting of mr may be an overestimation. 3. the right ventricular cavity is mildly dilated with mild global free wall hypokinesis. 4. there are simple atheroma in the descending thoracic aorta. 5. the aortic valve leaflets are moderately thickened. mild (1+) aortic regurgitation is seen. 6. the mitral valve leaflets are mildly thickened. moderate (2+) mitral regurgitation is seen. 7. moderate tricuspid regurgitation is seen. 8. significant pulmonic regurgitation is seen. 9. there is no pericardial effusion. 10 dr. was notified in person of the results on 1040 at . postbypass 1. patient is on epinephrine and norepinephrine infusions 2. the lv remains globally hypokinetic with an ef 20%. 3. a well seated mitral annuloplasty ring is seen in the mitral annulus. no mr is seen. 4. aortic regurgitation remain 1+ post bypass 5. aortic contour is smooth post decannulation. 6. dr. notified of findings 1457 on i certify that i was present for this procedure in compliance with hcfa regulations. interpretation assigned to , md, interpreting physician , r. csurg csru sched chest (portable ap) clip # reason: eval for pneumothorax s/p chest tube removal medical condition: 79 year old man s/p mvrepair reason for this examination: eval for pneumothorax s/p chest tube removal wet read: 8:01 pm no ptx. cmg, b/l small effusions, retrocardiac opacity. final report ap chest, 6:39 p.m., history: mitral valve repair. possible pneumothorax following chest tube removal. impression: ap chest compared to and 9: lung volumes are lower following removal of the endotracheal tube, with worsened atelectasis at both lung bases, left greater than right, and increase in small bilateral pleural effusion. increasing cardiac diameter could be due in part to lower lung volumes, and probably some mediastinal fluid collection, although there is no distention of mediastinal veins to suggest hemodynamic significance. no pneumothorax. upper lungs clear. right jugular sheath ends at the junction of the brachiocephalic veins. the study and the report were reviewed by the staff radiologist. dr. dr. approved: fri 1:32 pm imaging lab 08:30am blood wbc-8.4 rbc-3.55* hgb-11.0* hct-31.2* mcv-88 mch-31.1 mchc-35.4* rdw-14.8 plt ct-116* 07:10pm blood wbc-8.3 rbc-4.40* hgb-13.2* hct-37.7* mcv-86 mch-30.1 mchc-35.0 rdw-14.2 plt ct-190 05:30am blood pt-13.5* inr(pt)-1.2* 07:10pm blood pt-14.1* ptt-34.1 inr(pt)-1.2* 07:05am blood glucose-94 urean-38* creat-1.5* na-136 k-5.2* cl-105 hco3-28 angap-8 07:10pm blood glucose-112* urean-39* creat-1.5* na-141 k-4.7 cl-102 hco3-30 angap-14 brief hospital course: on mr. t mvrepair (#34mm ring) with dr. . xct=42min., cpb =68 minutes. he was transferred to the cvicu in stable condition on epinephrine, propofol and levophed drips. extubated later that evening. pod#1 he required milrinone due to decreased cardiac output. his rhythm was intermittently sr/afib-rate controlled. the milrinone was weaned to off with a stable cardiac output/cardiac index. all tubes and lines were discontinued when criteria was met.pod#3 he was transferred to the sdu for further telemetry and recovery. beta-blocker optimized as bp tolerated. mr. was restarted on his coumadin for his intermittent afib. despite discussions regarding the potential risks of stroke if not taking coumadin, mr. refuses.at time of discharge coumadin will be prescribed and he follow-up for inr/ coumadin dosing has been arranged. the remainder of his postoperative course was essentially uneventful. he continued to progress and on pod#6 he was discharged to home with vna. all follow-up appointments were advised. medications on admission: spironoloactone 12.5 mg daily mvi daily asa 81 mg daily vit c 500 mg daily simvastatin 20 mg daily digoxin 0.125 mg daily carvedilol 12.5 mg lisinopril 10 mg daily melatonin 3 mg qhs heparin iv drip discharge medications: 1. carvedilol 3.125 mg sig: two (2) po bid (2 times a day). disp:*120 (s)* refills:*0* 2. docusate sodium 100 mg capsule sig: one (1) capsule po bid (2 times a day). disp:*60 capsule(s)* refills:*0* 3. aspirin 81 mg , delayed release (e.c.) sig: one (1) , delayed release (e.c.) po daily (daily). disp:*30 , delayed release (e.c.)(s)* refills:*0* 4. oxycodone-acetaminophen 5-325 mg sig: 1-2 tablets po q4h (every 4 hours) as needed for pain. disp:*45 (s)* refills:*0* 5. simvastatin 10 mg sig: one (1) po daily (daily). disp:*30 (s)* refills:*0* 6. pantoprazole 40 mg , delayed release (e.c.) sig: one (1) , delayed release (e.c.) po q24h (every 24 hours). disp:*30 , delayed release (e.c.)(s)* refills:*0* 7. digoxin 125 mcg sig: one (1) po daily (daily). disp:*30 (s)* refills:*0* 8. warfarin 1 mg sig: md daily (daily). disp:*90 (s)* refills:*0* 9. furosemide 20 mg sig: one (1) po bid (2 times a day) for 7 days. disp:*14 (s)* refills:*0* 10. potassium chloride 20 meq tab sust.rel. particle/crystal sig: one (1) tab sust.rel. particle/crystal po q12h (every 12 hours) for 7 days. disp:*14 tab sust.rel. particle/crystal(s)* refills:*0* discharge disposition: home with service facility: homecare discharge diagnosis: mr s/p mv repair cad htn systolic chf rhd a fib pud with gastric bleed varicosities cri discharge condition: good discharge instructions: shower daily and pat incisions dry no lotions, creams or powders on any incision no lifting greater than 10 pounds for 10 weeks no driving for one month and until off narcotics call for fever greater than 100.5, redness or drainage followup instructions: see dr. in weeks see dr. in weeks see dr. in 4 weeks **daily inr results to be called into dr office for coumadin dosing procedure: extracorporeal circulation auxiliary to open heart surgery combined right and left heart cardiac catheterization coronary arteriography using two catheters angiocardiography of right heart structures annuloplasty diagnoses: other primary cardiomyopathies thrombocytopenia, unspecified mitral valve disorders congestive heart failure, unspecified hypertensive chronic kidney disease, unspecified, with chronic kidney disease stage i through stage iv, or unspecified atrial fibrillation chronic kidney disease, unspecified other specified surgical operations and procedures causing abnormal patient reaction, or later complication, without mention of misadventure at time of operation chronic systolic heart failure diseases of tricuspid valve 

Answer: The patient is high likely exposed to